Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCA

[1]  R. Simon,et al.  Protective effects of pretreatment with intracoronary nifedipine on myocardial ischemia and dysfunction , 1990, Cardiovascular Drugs and Therapy.

[2]  F. Crea,et al.  Ischemic Preconditioning During Coronary Angioplast Is Prevented by Glibenclamide, a Selective ATP‐Sensitive K+ Channel Blocker , 1994, Circulation.

[3]  A. Cribier,et al.  Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. , 1992, Journal of the American College of Cardiology.

[4]  J. Willems,et al.  Coronary hemodynamics and coronary flow reserve after intracoronary diltiazem in humans. , 1991, The American journal of cardiology.

[5]  H. De Geest,et al.  Effect of intravenous diltiazem on myocardial ischemia occurring during percutaneous transluminal coronary angioplasty. , 1989, The American journal of cardiology.

[6]  M. Forman,et al.  Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty. , 1988, Journal of the American College of Cardiology.

[7]  O. Hess,et al.  Prevention of coronary vasoconstriction by diltiazem during dynamic exercise in patients with coronary artery disease. , 1988, Journal of the American College of Cardiology.

[8]  C. Hanet,et al.  Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. , 1987, The American journal of cardiology.

[9]  M. Trivella,et al.  Dose-response scrutiny of coronary vasodilation after intracoronary verapamil in man. A quantitative cineangiographic study. , 1986, European heart journal.

[10]  P. Ganz,et al.  Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. , 1986, Circulation.

[11]  M. Kaltenbach,et al.  [Direct myocardial anti-ischemic effect of diltiazem in the human]. , 1986, Zeitschrift fur Kardiologie.

[12]  Y. Abiko,et al.  Protective effect of diltiazem on ultrastructural alterations induced by coronary occlusion and reperfusion in dog hearts. , 1986, Journal of molecular and cellular cardiology.

[13]  M. Cohen,et al.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. , 1985, Journal of the American College of Cardiology.

[14]  R. W. Brower,et al.  Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. , 1984, Circulation.

[15]  M. Kaltenbach,et al.  Prolonged application of pressure in transluminal coronary angioplasty. , 1984, Catheterization and cardiovascular diagnosis.

[16]  R. Hetzer,et al.  Intracoronary nifedipine in human beings: magnitude and time course of changes in left ventricular contraction/relaxation and coronary sinus blood flow. , 1983, Journal of the American College of Cardiology.

[17]  R. W. Brower,et al.  Regional cardioplegia and cardioprotection during transluminal angioplasty, which role for nifedipine? , 1983, European heart journal.

[18]  K. Kochsiek,et al.  Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption. , 1983, The American journal of cardiology.

[19]  M. Bertrand,et al.  Coronary Hemodynamics Following Intravenous or Intracoronary Injection of Diltiazem in Man , 1982, Journal of cardiovascular pharmacology.

[20]  S. Vatner,et al.  Effects of a Calcium‐channel Antagonist on Large and Small Coronary Arteries in Conscious Dogs , 1982, Circulation.

[21]  A. DeMaria,et al.  Efficacy of diltiazem in angina on effort: a multicenter trial. , 1982, The American journal of cardiology.

[22]  K. Mcintyre,et al.  Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial. , 1982, The American journal of cardiology.

[23]  C. Conti,et al.  Short- and long-term responses to diltiazem in patients with variant angina. , 1982, The American journal of cardiology.

[24]  P. Pool,et al.  Long-term efficacy of diltiazem in chronic stable angina associated with atherosclerosis: effect on treadmill exercise. , 1982, The American journal of cardiology.

[25]  D. Baim,et al.  Efficacy of diltiazem for control of symptoms of coronary arterial spasm. , 1980, The American journal of cardiology.

[26]  W. Nayler,et al.  Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. , 1980, The American journal of cardiology.

[27]  M. Nakamura,et al.  Myocardial blood flow following experimental coronary occlusion. Effects of diltiazem. , 1980, Chest.

[28]  J. Williamson,et al.  Effects of Nifedipine on Myocardial Perfusion and Ischemic Injury in Dogs , 1978, British journal of clinical practice. Supplement.

[29]  G. Fleckenstein-Grün,et al.  Cardiovascular protection by Ca antagonists. , 1980, European heart journal.

[30]  R. E. Clark,et al.  Nifedipine: a myocardial protective agent. , 1979, The American journal of cardiology.